Open AccessBarriers to access to antiretroviral treatment for HIV-positive tuberculosis patients in Windhoek, Namibia
Author(s) -
Stefanie Seeling,
Farai Mavhunga,
Albertina Thomas,
Bettina Adelberger,
Timo Ulrichs
Publication year - 2014
Publication title -
international journal of mycobacteriology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 20
eISSN - 2212-554X
pISSN - 2212-5531
DOI - 10.1016/j.ijmyco.2014.07.009
Subject(s) - antiretroviral treatment , human immunodeficiency virus (hiv) , tuberculosis , antiretroviral therapy , medicine , virology , family medicine , environmental health , viral load , pathology
Namibia faces a high burden of tuberculosis (TB) and HIV-infection. In 2011, 50% of the TB patients were co-infected with HIV. While all patients co-infected with TB and HIV are eligible for antiretroviral treatment (ART), only 54% were reported to have received ART according to national data.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom